Every month, we huddle for another edition of Across the Consortium to recap the progress of our member institutions. This month, we celebrate new advancements that challenge traditional precepts of imaging, point to new modes of suppressing tumor growth, and identify side effects of current treatments. You will see members procuring serious funding to answer serious questions and meeting the urgent needs of patients head on with brand new clinical trials. Circle up!
Barriers: to win this war against cancer, they all must come down. In this month’s edition of Across the Consortium, discover how members of the Big Ten Cancer Research Consortium are bringing down barriers. Interdisciplinary partnerships are overcoming obstacles to inoperable cancers; laser-imaging and creative tests are being leveraged to break down barriers to early diagnosis; immunotherapies are breaking down barriers to once-and-for-all remission; new predictive screening models and population-specific cancer programs are breaking down barriers to treatment of certain populations; volunteers and grants are breaking down barriers to research. All this and more, in this month’s edition of Across the Consortium!
Initiative: the proactive power of progress. This key trait of leadership is exhibited by each of the Big Ten Cancer Centers. Exciting displays of initiative in the fight against cancer fill this month’s edition of Across the Consortium. Engagement in national enrollment-boosting programs; patient-centered precision medicine initiatives; hosting a research summit and publishing studies in nationwide research initiatives; a nationally-recognized fundraising event; novel discoveries; and the development of game-changing diagnostic technology and immunotherapy treatments. Don’t miss this action-packed edition of Across the Consortium!
Many people excel in sports, and even amateurs get lucky now and then. But it is the relentlessly consistent accomplishment of great – and crucial – plays that makes a legend. In this month’s edition of Across the Consortium, we celebrate such plays by the unyielding Big Ten Cancer Centers. Pioneering research aims to nail important questions of our time and offer hope to countless many, from the promise of novel, natural cancer-killers to targeted cancer therapies, liquid biopsies, and bio-dynamic imaging. Meanwhile, many members institutions pull through with varsity fund-raising. Take a look Across the Consortium!
Big Ten cancer centers continue to make gains in cancer research and treatment. In this edition of Across the Consortium, we highlight research from our member institutions in prostate, neuroendocrine, blood, pancreatic, and other cancers; we celebrate with the University of Iowa Holden Comprehensive Cancer Center upon its receiving a SPORE grant for new research projects on neuroendocrine tumors; we congratulate those strategically entering into within the cancer research community; and we root for members advancing in cancer prevention programs.
The fight against cancer is greatly defined by the sheer multitude of challenges involved, the victory over which requires unique capabilities. In this month’s edition of Across the Consortium, see shining examples of the unique skills, expertise, knowledge, and passion of each member institution, and be reminded why we are stronger together.
A game-plan is strategy in motion – the key to a winning plan is insightful strategy. The team-research culture of the Big Ten Cancer Research Consortium fosters such insight, and Big Ten CRC member institutions are positioned to win. In this month’s edition of Across the Consortium, we take note of crucial plays made possible by the members’ plan to rapidly drive from ideas to new approaches to cancer treatment.
Opportunity is knocking Across the Consortium, and member institutions of The Big Ten Cancer Research Consortium are opening doors to greater innovation and impact. Through powerful partnerships, visionary leadership, an “all-in” investment in infrastructure, research, and outreach, members are unlocking answers for today, promise for tomorrow, hope that reaches beyond borders, and decades of vision now realized.
The Big Ten Cancer Research Consortium‘s “Across the Consortium” is your front-row seat to all the latest action in cancer research conducted by our member institutions.
As the year is winding down Big Ten university researchers have not lost their momentum. As we look back over this past year, great accomplishments along with generous grants and gifts are the hallmarks worthy of celebration.
Big Ten CRC members are committed to improving treatment paradigms, and they continue to do just that through rigorously investigating correlations with far-reaching effects. A few examples includenew insight into restoring cancer suppressor activity to damaged genes and identifying specific genes correlated with lung cancer tumor formation and metastasis; a comprehensive study that shows the relationship of mastectomy to survival; and new developments that promise to revolutionize clinical tests used in diagnosing and treating different cancers.
We look forward to the further advances that will come from Big Ten cancer centers in 2016 and beyond. For now, here are a few highlights from Across the Consortium:
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube